Skip to main content
. 2020 Jun 30;9(7):2055. doi: 10.3390/jcm9072055

Table 2.

Demographic data and clinical characteristics of mild cognitive impairment (MCI) with type 2 diabetes (T2D)-MCI and MCI subjects without diabetes (ND-MCI).

T2D-MCI
n = 39
ND–MCI
n = 37
p
Age *, mean (sd) 74.21 (4.58) 76.68 (6.30) 0.06
Female, n (%) 18 (46.15) 22 (59.46) 0.25
Education (years) *, mean (sd) 7.44 (2.98) 8.27 (3.90) 0.30
MMSE ^, median (iqr) 26.30 (2.40) 25.70 (2.00) 0.10
HbA1c *, mean (sd) 7.62 (1.67) 5.30 (0.80) 0.01
BMI *, mean (sd) 28.33 (5.23) 23.63 (2.50) 0.00
Hypertension, n (%) 26 (66.67) 18 (48.65) 0.11
Neuropathy, n (%) 6 (15.38) 0 (0.00) 0.01
Nephropathy, n (%) 3 (7.69) 0 (0.00) 0.09
Chronic Renal Failure, n (%) 2 (5.13) 1 (2.70) 0.59
Retinopathy, n (%) 13 (33.33) 0 (0.00) 0.00
Supra-aortic Trunks Arterial Disease, n (%) 2 (5.13) 1 (2.70) 0.59
Obliterative Arteriopathy of Lower Limbs, n (%) 5 (12.82) 2 (5.41) 0.26
Myocardial Ischemia, n (%) 9 (23.08) 14 (37.84) 0.16

p from t-test for normally distributed variables (*), Mann–Whitney U test for non-normally distributed variables (^), and χ² for dichotomic variables.